• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Meldonium

Meldonium Tests Reignite Doping Scandal in Russian Athletics

By
Reuters
Reuters
Down Arrow Button Icon
By
Reuters
Reuters
Down Arrow Button Icon
March 21, 2016, 10:45 AM ET
Maria Sharapova Announces She Failed Doping Test
Photograph by Kevork Djansezian—Getty Images

Four Russian track-and-field athletes have tested positive for the banned drug meldonium, Russia’s athletics chief said on Monday, a disclosure which could further damage Moscow’s efforts to overturn a doping ban in time for the Rio Olympics.

At least 16 Russian sportsmen and women, including world tennis star Maria Sharapova and speed skating Olympic gold-medallist Semion Elistratov, have been caught using meldonium since it was banned by the World Anti-Doping Agency on Jan. 1.

Despite warnings from sports officials that a number of other Russian competitors could have taken the substance, Sports Minister Vitaly Mutko told Reuters on March 11 that meldonium had nothing to do with athletics in his country.

But the Russian Athletics Federation (ARAF) said on Monday four athletes had tested positive at the Russian Winter Indoor Athletics Championships in February.

“We have information that four people gave positive tests for meldonium. We will deal with this today,” the Interfax news agency quoted ARAF head Dmitry Shlyakhtin as saying.

One of the athletes named was Russian long-distance running champion Andrei Minzhulin. It was unclear whether sprinter Nadezhda Kotlyarova, who revealed on Sunday she had taken meldonium, was included among the four.

The scandal will complicate Russia’s campaign to prove it is compliant with anti-doping standards after being suspended from international competition last year following revelations of widespread cheating and corruption.

If it cannot get the suspension lifted, Russian athletes will miss the Olympics starting in Rio de Janeiro on Aug. 5 – a humiliating blow to a country that has long drawn pride and prestige from its record as an athletics superpower.

The International Association of Athletics Federations (IAAF) did not immediately reply to a request for comment.

Minzhulin, who won the men’s 5,000-meter final at the Russian championships in February, said 55 nanograms of meldonium had been found in his blood. He and Kotlyarova both said they stopped using the drug before it was banned.

“I admit the fact of taking meldonium, but I took the substance when it was not considered doping and stopped taking it in good time,” R-Sport news agency quoted him as saying

Meldonium has a half-life of between four and six hours but can remain in the human body for significantly longer, said Latvian manufacturer Grindeks.

“Terminal elimination from the body may last for several months,” said Grindeks spokeswoman Ilze Gailite in written comments to Reuters.

“It depends on a variety of factors such as dose, duration of treatment … type of samples (blood or urine) used for detection of the substance.”

Since former world tennis number one Sharapova admitted using meldonium, at least 100 athletes from multiple countries have tested positive for the drug, which is used to treat diabetes and low magnesium and has been linked to increased sporting performance.

Meldonium is particularly popular in Russia and the former Soviet Union, however, having been invented in Latvia and used to help Soviet soldiers fight at high altitude in the 1980s.

R-Sport reported that around 40 Russian athletes from more than 10 different sports had tested positive for meldonium in the first two months of 2016.

Mutko said on Monday the cases of meldonium used in Russian athletics should not be connected to his country’s preparations for the Olympics, and athletes would be tested at least three times before leaving for Rio.

“Everyone who is preparing for the games is being monitored. But the issue of meldonium is a separate issue,” TASS news agency quoted him as saying.

“The testing plans are completely clear. Our sportsmen have been warned – they can be tested at any time. Their task is to prepare for international competition.”

About the Author
By Reuters
See full bioRight Arrow Button Icon

Latest in

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in

Woman CEO speaks in boardroom at meeting.
NewslettersCFO Daily
One prediction isn’t enough — Why CEOs are shifting to wartime planning
By Sheryl EstradaMarch 24, 2026
8 minutes ago
United States President Donald Trump walks toward the White House upon his arrival in Washington, DC, from Memphis, Tennessee, United States, on March 23, 2026.
EconomyIran
Wall Street is ‘bewitched’ by positive news on Iran, says UBS, and investors want to believe the war is over without verifiable information
By Eleanor PringleMarch 24, 2026
11 minutes ago
CryptoCryptocurrency
Invesco takes over Superstate’s $900 million T-bill fund as Wall Street accelerates tokenization push
By Jeff John RobertsMarch 24, 2026
31 minutes ago
dog
Commentarycorporate boards of directors
What avalanche safety training can teach corporate boards about bad decisions
By Jane SadowskyMarch 24, 2026
31 minutes ago
NewslettersTerm Sheet
The rise and uncertain future of $29 billion AI coding startup Cursor
By Allie GarfinkleMarch 24, 2026
49 minutes ago
EconomyMarkets
Trump searches for an exit strategy in Iran as $100 oil looms over the midterms
By Jim EdwardsMarch 24, 2026
57 minutes ago

Most Popular

Commentary
The Treasury just declared the U.S. insolvent. The media missed it
By Fortune EditorsMarch 23, 2026
21 hours ago
Personal Finance
Current price of gold as of March 23, 2026
By Fortune EditorsMarch 23, 2026
23 hours ago
Economy
It took 200 years for national debt to hit $1 trillion. Annual interest alone now exceeds that—a 'crushing legacy we must reverse,' says budget chair
By Fortune EditorsMarch 23, 2026
24 hours ago
Personal Finance
Current price of oil as of March 23, 2026
By Fortune EditorsMarch 23, 2026
23 hours ago
Health
Trump has TACO'd again, this time in Iran, sparking a $1.7 trillion stock market rally in minutes, even as peace talks are in question
By Fortune EditorsMarch 23, 2026
20 hours ago
Success
Dairy Queen CEO says he learned from Warren Buffett being the 'smartest person in the world' isn't the most important attribute for success
By Fortune EditorsMarch 21, 2026
3 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.